Park Ridge, Illinois Clinical Trials

A listing of Park Ridge, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 529 clinical trials
featured
Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

www.MyelofibrosisResearch.com Myelofibrosis (MF) is a bone marrow illness that affects blood-forming tissues in the body. MF disturbs the body's normal production of blood cells, causing extensive scarring in the bone marrow. This leads to severe anemia, weakness, fatigue, and an enlarged spleen. The purpose of this study is to assess …

Loyola University Medical Ctr /ID# 219048
 (9.2 away) Contact site
  • 164 views
  • 29 Apr, 2021
  • +224 other locations
featured
The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study for Occlusive and Re-stenotic Fem-pop Revascularization - 2 Trial: TORUS 2

The primary objective of the TORUS 2 IDE Clinical Study is to evaluate the safety and effectiveness of the TORUS Stent Graft System in the treatment of obstructive atherosclerotic lesions of the native SFA or the superficial femoral and/or proximal popliteal arteries.

AMITA Health
 (8.9 away) Contact site
  • 17 views
  • 23 Nov, 2020
  • 1 location
featured
Art Therapy Research Study.

This study is looking for people who have early stage Alzheimer’s. The study is testing the effects of art therapy on relationships.

Advocate Memory Center
 (0.3 away) Contact site
  • 0 views
  • 29 Jun, 2021
  • 1 location
featured
A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy (SAPPHIRE)

This is an open-label, randomized (1:1), multicenter, Phase 3 clinical trial evaluating the safety and efficacy of nivolumab in combination with investigational agent sitravatinib compared to docetaxel in patients with advanced non-squamous NSCLC who have previously experienced radiographic disease progression on or after treatment with platinum-based chemotherapy in combination with …

squamous non-small cell lung cancer
advanced non-squamous non-small cell lung cancer
non-squamous non-small cell lung cancer
cancer chemotherapy
lung carcinoma
Illinois Cancer Specialists - Niles
 (1.9 away) Contact site
  • 199 views
  • 28 Jun, 2021
  • +182 other locations
featured
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

The purpose of this study is to evaluate the efficacy and safety of pemigatinib in participants with previously treated locally advanced/metastatic or surgically unresectable solid tumor malignancies harboring activating FGFR mutations or translocations.  

measurable disease
FGFR1
malignancies
cancer
solid tumors
Illinois Cancer Specialists
 (8.3 away) Contact site
  • 46 views
  • 14 Dec, 2020
  • +61 other locations
featured
Phase 2 Trial of MRTX849 in Combination with Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation (KRYSTAL-7)

This Phase 2 study evaluates the clinical activity and safety of MRTX849 in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and any PD-L1 TPS.

KRAS
pembrolizumab
USOR - Illinois Cancer Specialists - Niles
 (1.9 away) Contact site
  • 0 views
  • 08 Jul, 2021
  • +39 other locations
featured
A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients With Advanced Solid Tumors With KRAS G12C Mutation

Evaluates the safety, tolerability, pharmacokinetics, metabolites, pharmacodynamics, and clinical activity of MRTX849 in patients with advanced solid tumors with a KRAS G12C mutation. MRTX849 is an orally-available small molecule inhibitor of KRAS G12C.

advanced solid tumor
malignant solid tumor
solid tumor
Mirati Research Site
 (1.9 away) Contact site
  • 405 views
  • 08 Jul, 2021
  • +72 other locations
featured
Arise 2 - A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia

This is a randomized, placebo-controlled, double-blind, crossover study of oral BTD-001 in adults with Idiopathic Hypersomnia.  

hypersomnia
Northshore Sleep Medicine
 (7.8 away) Contact site
  • 607 views
  • 23 Nov, 2020
  • +17 other locations
featured
Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Mirati Research Site
 (8.1 away) Contact site
  • 342 views
  • 08 Nov, 2020
  • +37 other locations
featured
Validation of a wearable mechano-acoustic sensor platform for collecting speech, language, and social interaction data

This study is looking for people who live in the Evanston, IL, area and have mild cognitive impairment or mild-to-moderate Alzheimer’s. The study is testing a new type of voice sensor.

mild cognitive impairment
cognitive impairment
Northwestern University
 (8.9 away) Contact site
  • 0 views
  • 15 Sep, 2020
  • 1 location